MAPKAPK2 and neoplasm: We could confirm that Cxcl-12 expression in the tumor microenvironment of LysM-MK2-KO mice was dramatically reduced, providing direct support that myeloid MK2 is necessary for Cxcl-12 expression in vivo (Figure 4A).